Search by Drug Name or NDC
NDC 00338-9543-05 SODIUM CHLORIDE 9 g/1000mL Details
SODIUM CHLORIDE 9 g/1000mL
SODIUM CHLORIDE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is SODIUM CHLORIDE.
Product Information
| NDC | 00338-9543 |
|---|---|
| Product ID | 0338-9543_d7d7d10d-5ef6-479e-a4f4-602f765dfc15 |
| Associated GPIs | 79750010002021 |
| GCN Sequence Number | 001210 |
| GCN Sequence Number Description | 0.9 % sodium chloride IV SOLN 0.9 % INTRAVEN |
| HIC3 | C1B |
| HIC3 Description | SODIUM/SALINE PREPARATIONS |
| GCN | 02962 |
| HICL Sequence Number | 008255 |
| HICL Sequence Number Description | 0.9 % SODIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | SODIUM CHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | sodium chloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 9 |
| Active Ingredient Units | g/1000mL |
| Substance Name | SODIUM CHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA016677 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00338-9543-05 (00338954305)
| NDC Package Code | 0338-9543-05 |
|---|---|
| Billing NDC | 00338954305 |
| Package | 1000 mL in 1 BAG (0338-9543-05) |
| Marketing Start Date | 1970-12-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |